Permira to fund TBS buyout via levloan market in rude health
Pantheon Healthcare, the pharmaceutical developer owned by Permira, is marketing a €300m loan to finance the acquisition of Telematic and Biomedical Services with bankers saying demand for leveraged loans shows no signs of abating.
Since Permira got its hands on Pantheon in 2014, it has played an active role in the consolidation of the private healthcare services industry in Italy. TBS Group, which provides integrated support in clinical engineering, will become Pantheon’s second acquisition in the sector.
On May 12, Permira
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: firstname.lastname@example.org or find out more online here.